A hybrid mode signing ceremony was held on 15 June 2022 between representatives of PolyU and Increasepharm(HK) establishing a joint laboratory for new drugs discovery.Zoom In

PolyU has partnered with Increasepharm(HK) to establish the PolyU-Increasepharm Joint Research Laboratory for New Drug Development, with the generous support of HK$10 million from the pharmaceutical company.

 

The joint laboratory will be managed by PolyU Research Centre for Chinese Medicine Innovation (RCMI) and focus on the development of new Chinese Medicine-based drugs.

 

“The joint laboratory will leverage Increasepharm’s edge in synthetic chemistry and manufacture of new drugs. It will help in the commercialisation of PolyU’s drug development outputs,” said Prof. Wong Man-sau, Associate Dean of the Faculty of Applied Science & Textiles and Director of RCMI.

 

Prof. Wong added that the joint laboratory will develop novel herbal-based drugs for dementia and cognitive impairment, as well as conducting research on a ground-breaking drug delivery system to open the way for the development of new drugs for eye disease. The laboratory will also serve to nurture talents in new drugs development.